Factors Associated with Delayed Hepatitis B Viral Suppression on Tenofovir Among HBV-HIV Coinfected Patients in the CNICS Cohort

BACKGROUND: Despite widespread use in HIV and hepatitis B virus (HBV) infection, the effectiveness of tenofovir (TDF) has not been studied extensively outside of small HBV-HIV coinfected cohorts. We examined the effect of prior lamivudine treatment (3TC) and other factors on HBV DNA suppression with...

Full description

Saved in:
Bibliographic Details
Main Authors: Kim, H. Nina, Rodriguez, Carla V., Van Rompaey, Stephen, Eron, Joseph J., Thio, Chloe L., Crane, Heidi M., Overton, Edgar T., Saag, Michael S., Martin, Jeffrey, Geng, Elvin, Mugavero, Michael, Rodriguez, Benigno, Mathews, W. Christopher, Boswell, Stephen, Moore, Richard, Kitahata, Mari M.
Format: Artigo
Language:Inglês
Published: 2014
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3981874/
https://ncbi.nlm.nih.gov/pubmed/24500175
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/QAI.0000000000000126
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items